Clopidogrel treatment in a patient with ticlopidine-induced hepatitis following percutaneous coronary stenting

被引:0
|
作者
Anselmino, M. [1 ]
Moretti, C. [1 ]
Ravera, L. [1 ]
Sheiban, I. [1 ]
机构
[1] Univ Turin, Div Cardiol, Dept Med, San Giovanni Battista Hosp, I-10126 Turin, Italy
来源
MINERVA CARDIOANGIOLOGICA | 2010年 / 58卷 / 02期
关键词
Cerebrovascular disorders; Cardiovascular diseases; Hepatitis;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Thienopyridines are commonly prescribed antiplatelets drugs, extremely useful for the acute and chronic management of patients with cerebrovascular and cardiovascular diseases. The occurrence of their side effects is fortunately uncommon, although unpredictable. We thereby describe a case of prescription of clopidogrel in a patient with ticlopidine-induced hepatitis confirmed by liver biopsy that had undergone multiple percutaneous coronary stenting procedures necessitating subsequent compulsory antiplatelets treatment. The description of this exceptional clinical case is of relevant knowledge to orientate a physician treating a patient with absolute need of antiplatelets and history of previous drug-induced reactions.
引用
收藏
页码:277 / 280
页数:4
相关论文
共 50 条
  • [41] Clopidogrel is associated with better in-hospital and 30-day outcomes than ticlopidine after coronary stenting
    L'Allier, PL
    Aronow, HD
    Cura, FA
    Bhatt, DL
    Albirini, A
    Schneider, JP
    Topol, EJ
    Ellis, SG
    CANADIAN JOURNAL OF CARDIOLOGY, 2003, 19 (09) : 1041 - 1046
  • [42] Development of a clopidogrel card for patients following percutaneous coronary intervention
    Antoniou, S.
    Richter, A.
    Rothman, M. T.
    PHARMACY WORLD & SCIENCE, 2008, 30 (04): : 376 - 377
  • [43] Ticagrelor as Compared to Clopidogrel Following Percutaneous Coronary Intervention for Acute
    Wiens, Evan J.
    Leon, Silvia J.
    Whitlock, Reid
    Tangri, Navdeep
    Shah, Ashish H.
    AMERICAN JOURNAL OF CARDIOLOGY, 2023, 198 : 26 - 32
  • [44] Predictors of Low Clopidogrel Adherence Following Percutaneous Coronary Intervention
    Muntner, Paul
    Mann, Devin M.
    Woodward, Mark
    Choi, James W.
    Stoler, Robert C.
    Shimbo, Daichi
    Farkouh, Michael E.
    Kim, Michael C.
    AMERICAN JOURNAL OF CARDIOLOGY, 2011, 108 (06): : 822 - 827
  • [45] Incidence and clinical course of thrombotic thrombocytopenic purpura due to ticlopidine following coronary stenting
    Steinhubl, SR
    Tan, WA
    Foody, JM
    Topol, EJ
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (09): : 806 - 810
  • [46] Comparison between ticlopidine and clopidogrel in patients with ST-segment elevation myocardial infarction treated with coronary stenting
    De Luca, G
    Suryapranata, H
    van't Hof, AWJ
    Ottervanger, JP
    Hoorntje, JCA
    Gosselink, ATM
    Damibrink, JHE
    Zijlstra, F
    Boer, MJC
    THROMBOSIS AND HAEMOSTASIS, 2004, 91 (06) : 1084 - 1089
  • [47] Comparison of anticoagulation, combined ticlopidine and aspirin, and aspirin alone therapy following coronary stenting
    Galli, S
    Trabattoni, D
    Loaldi, A
    Montorsi, P
    Fabbiocchi, F
    Sganzerla, P
    Grancini, L
    Bartorelli, AL
    CIRCULATION, 1996, 94 (08) : 3999 - 3999
  • [48] Ambulatory Use of Ticlopidine and Clopidogrel in Association with Percutaneous Coronary Revascularization Procedures in a National Managed Care Organization
    Shatin, Deborah
    Schech, Stephanie D.
    Brinker, Allen
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2002, 15 (03) : 181 - 186
  • [49] SUSTAINED GRANULOCYTE RECOVERY AFTER G-CSF IN A PATIENT WITH TICLOPIDINE-INDUCED SEVERE APLASTIC-ANEMIA
    ARRIBALZAGA, K
    GARCIASUAREZ, J
    LOPEZRUBIO, M
    KRSNIK, I
    CALERO, MA
    DELCAMPO, JF
    AMERICAN JOURNAL OF HEMATOLOGY, 1995, 50 (04) : 313 - 313
  • [50] The Worry About Clopidogrel "Nonresponsiveness" Identification and Treatment in the Post-Percutaneous Coronary Intervention Patient
    Gurbel, Paul A.
    Tantry, Udaya S.
    Shuldiner, Alan R.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2009, 2 (11) : 1102 - 1104